Antimotility agents

/Tag:Antimotility agents

SAFETY OF ANTIMOLITY AGENT USE DURING TREATMENT FOR CLOSTRIDIOIDES DIFFICILE INFECTION IN MALIGNANT HEMATOLOGY INPATIENTS

Background: Guidelines on the treatment of Clostridioides (Clostridium) difficile infection (CDI) have historically recommended avoiding antimotility agents (AAs) in patients with active CDI based on theoretical concerns that administration of AAs may precipitate serious adverse [...]

By | 2019-03-11T14:21:20+00:00 March 11th, 2019|Hospital Medicine 2019, Patient Safety, Research|Comments Off on SAFETY OF ANTIMOLITY AGENT USE DURING TREATMENT FOR CLOSTRIDIOIDES DIFFICILE INFECTION IN MALIGNANT HEMATOLOGY INPATIENTS